February 23, 2021
Biomerics, a leading mid-market medical device contract manufacturer, announced it is doubling its manufacturing footprint in the La Zeta Free Trade Zone in Cartago, Costa Rica. Biomerics held a joint groundbreaking ceremony with La Zeta and CINDE on Friday, February 12, 2021.
The expansion is via a new greenfield plant adjacent to Biomerics current operations and includes extrusion, injection molding, micro metal processing, and cleanroom assembly process. The new facility construction totaling 110,000 sq. ft. will reflect Biomerics vertically integrated, full-service business model and will include engineering labs, quality inspection labs, controlled environment manufacturing, office space, class 7 clean rooms, packaging, and warehouse facilities.
Biomerics currently employs 175 people at its 50,000 sq. ft. facility focused on extrusion, laser processing, high volume assembly, and packaging. The expansion is in support of active transfer programs with strategic customers and is expected to double its number of Costa Rican employees over the next three years.
“This expansion is in line with our vision to be the leading interventional contract manufacturer,” stated Travis Sessions, Biomerics CEO. “Customers have requested that we build a vertically integrated operation in Costa Rica to provide cost-effective high volume manufacturing for the interventional market.”
“We are excited for the value that this expansion brings to our existing customer base in Costa Rica and interventional OEM partners around the globe,” stated Chris Richardson, Biomerics Director of Sales and Marketing. “The thriving medical device ecosystem in Costa Rica aligns well with Biomerics’ culture and innovative core.”
Construction is expected to be completed by Q4 2021 and will be celebrated with an open house.